Tags Archives: ecmo

Perfusfind S.L.

Context Poisoning may lead to respiratory failure, shock, cardiac arrest, or death. Extracorporeal membrane oxygenation (ECMO) may be used to provide circulatory support, termed venoarterial (VA) ECMO; or respiratory support..

Perfusfind S.L.

Extracorporeal membrane oxygenation (ECMO) for cardiac failure is on the rise worldwide. Some challenges, such as limb ischemia and thrombotic or hemorrhagic events, are well-recognized. Newer data suggests that ventricle..

Perfusfind S.L.

To the Editor: Venovenous extracorporeal membrane oxygenation (ECMO) was considered early in the pandemic to rescue the most severe forms of coronavirus disease (COVID-19)–associated acute respiratory distress syndrome (ARDS). The..

Perfusfind S.L.

Abstract Venovenous extracorporeal membrane oxygenation (VV ECMO) is commonly used to support patients with severe respiratory failure with adequate cardiac function by providing gas exchange while allowing for lung-protection, lung..

Perfusfind S.L.

Abstract Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) provides a temporary support system for patients with cardiogenic shock refractory to conventional medical therapies. It has been reported that levosimendan may facilitate VA-ECMO..

Perfusfind S.L.

Abstract Extra-corporeal membrane oxygenation (ECMO) is growing in adoption and popularity, as demonstrated by the international registry maintained by the Extracorporeal Life Support Organization (ELSO). While initially an adaptation of..

Perfusfind S.L.

Abstract Background Pulsatile flow protects vital organ function and improves microcirculatory perfusion during extracorporeal membrane oxygenation (ECMO). Studies revealed that pulsatile shear stress plays a vital role in microcirculatory function..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation is challenged by several potential complications. Adverse neurologic events such as intracranial hemorrhages, strokes, seizures, and brain death are among the most detrimental and even catastrophic..

Perfusfind S.L.

Abstract The use of extracorporeal membrane oxygenation (ECMO) in patients with severe cardiorespiratory failure has seen significant growth in the last decade. Despite this, there is paucity of data surrounding..

Perfusfind S.L.

Abstract COVID-19 can be associated with acute respiratory distress syndrome (ARDS) which increases the likelihood of morbidity and mortality. Ventilator-induced lung injury (VLI) is a known complication of mechanical ventilation (MV) and..

Perfusfind S.L.

Abstract This study describes the use of bivalirudin in children on extracorporeal membrane oxygenation (ECMO). Pediatric patients receiving bivalirudin were compared to patients receiving heparin as the anticoagulant on ECMO...

Perfusfind S.L.

Abstract Objectives We investigated whether intra-aortic balloon pump (IABP) combined with venoarterial extracorporeal membrane oxygenation (VA-ECMO) was associated with favourable neurological outcomes for patients after the return of spontaneous circulation..

Perfusfind S.L.

Abstract Neonatal extracorporeal membrane oxygenation (ECMO) is a life-saving procedure for critically ill neonates suffering from a potentially reversible disease, causing severe cardiac and/or respiratory failure and refractory to maximal..

Perfusfind S.L.

Zeraatain's RMRC technique in central ECMO cannulation instead of direct cannulation of ascending aorta as well as RA with special ECMO cannulas i usually use routine cannulation devices and reinforce..

Perfusfind S.L.

Abstract Objective  To explore whether pre-cannulation international normalized ratio (INR) is associated with in-hospital mortality in veno-arterial extracorporeal membrane oxygenation (VA-ECMO) patients. Design Retrospective observational cohort study. Setting Quaternary care..

Perfusfind S.L.

Abstract Background  has become accepted as a rescue therapy for cardiopulmonary shock, and there have been over 100,000  (ECMO) cases since 1987. Rapid growth has presented ethical challenges and concerns. Here, we discuss..

Perfusfind S.L.

Abstract Purpose: Extracorporeal membrane oxygenation (ECMO) use for severe coronavirus disease 2019 (COVID‑19) patients has increased during the course of the pandemic. As uncertainty existed regarding patient’s outcomes, early guidelines..

Perfusfind S.L.

Abstract Venovenous extracorporeal membrane oxygenation (VV-ECMO) has been used as a rescue therapy for patients with refractory coronavirus disease (COVID-19)–associated severe acute respiratory distress syndrome (ARDS) with survival rates similar..

Perfusfind S.L.

Abstract Over 50 years ago, visionary researchers began work on an extracorporeal artificial placenta to support premature infants. Despite rudimentary technology and incomplete understanding of fetal physiology, these pioneering scientists..

Perfusfind S.L.

Abstract Background Weaning from venovenous extracorporeal membrane oxygenation (VV-ECMO) is not well studied. VV-ECMO can be discontinued when patients tolerate non-injurious mechanical ventilation (MV) during a sweep gas off trial..

Perfusfind S.L.

Abstract Prior to COVID-19, a large international cohort study estimated that acute respiratory distress syndrome (ARDS) accounts for 10% of all admissions to the ICU and almost a quarter of..

Perfusfind S.L.

Abstract Objective: The aim was to evaluate the performance of a newly developed magnetically suspended centrifugal pump head intended for use as a ventricular assistance device with a newly developed..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) support is indicated in patients who are refractory to treatment, those with cardiogenic shock or respiratory failure and those with exacerbations eligible for heart and..

Perfusfind S.L.

Abstract Left ventricular (LV) distention and pulmonary congestion are major complications inherent to venoarterial extracorporeal membrane oxygenation (ECMO). This study aimed to quantitatively compare the hemodynamic differences between common circulatory..

Perfusfind S.L.

Higher or lower oxygen targets and survival and Predicting V-A ECMO survival with SAVE Lectures on lower or higher oxygen targets and survival in critical care patients. Using the SAVE..

Perfusfind S.L.

Disclaimer These guidelines describe useful and safe practice for extracorporeal life support (ECLS, ECMO) but these are not necessarily consensus recommendations. These guidelines are not intended as a standard of..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is a therapy used in severe cardiopulmonary failure. Blood is pumped through an artificial circuit exposing it to nonphysiologic conditions, which promote platelet activation and..

Perfusfind S.L.

Abstract Systemic hypertension (HTN) is a recognized complication of veno-venous (VV) extracorporeal membrane oxygenation (ECMO) in children. We sought to determine the prevalence and associated features of HTN in a..